8-K: Regeneron Pharmaceuticals, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-06 AccNo: 0001104659-26-113895 Size: 206 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Finan
Filed: 2026-10-06 AccNo: 0001104659-26-113895 Size: 206 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Finan